Earth Science Tech (ETST) Change in Accured Expenses (2012 - 2026)
Earth Science Tech (ETST) posted Change in Accured Expenses of -$200101.0 for Q1 2026, up 84.05% on a QoQ basis from -$1.3 million in Q4 2025, and down 114.55% year-over-year from $1.4 million in Q1 2025.
Earth Science Tech (ETST) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Earth Science Tech's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$200101.0 for Q1 2026.
- Quarterly Change in Accured Expenses fell 114.55% year-over-year to -$200101.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$968417.0 (down 167.69% YoY) and the FY2026 annual result came in at -$968417.0, down 167.69% from the prior year.
- Change in Accured Expenses was -$200101.0 for Q1 2026 at Earth Science Tech, up from -$1.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.4 million in Q1 2025 and bottomed at -$1.3 million in Q4 2025.
- A 5-year average of $89720.2 and a median of $7000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 1663.51% — and 2025, when it surged 10622.08%.
- Earth Science Tech's Change in Accured Expenses stood at -$839125.0 in 2022, then soared by 100.83% to $7000.0 in 2023, then tumbled by 1663.51% to -$109446.0 in 2024, then slumped by 1045.99% to -$1.3 million in 2025, then surged by 84.05% to -$200101.0 in 2026.
- Business Quant data shows ETST's Change in Accured Expenses at -$200101.0 in Q1 2026, -$1.3 million in Q4 2025, and $155218.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -12.70 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | - |
| 10 | Earth Science Tech | 33.70 Mn | 31.55 Mn | 6.27 Mn | -200,101.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200,101.00 |
| Mar 31, 2026 | -200,101.00 |
| Dec 31, 2025 | -1.25 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Sep 30, 2025 | 155,218.00 |
| Sep 30, 2025 | 155,218.00 |
| Jun 30, 2025 | 330,709.00 |
| Jun 30, 2025 | 330,709.00 |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -109,446.00 |
| Dec 31, 2024 | -109,446.00 |
| Sep 30, 2024 | 168,192.00 |
| Sep 30, 2024 | 168,192.00 |
| Jun 30, 2024 | -3,143.00 |
| Jun 30, 2024 | -3,143.00 |
| Mar 31, 2024 | 833,176.00 |
| Mar 31, 2024 | 833,176.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |